MIRIA Development of Antimicrobial, Antiviral, and Antifungal Nanocoatings for Everyday Surfaces
- Coordinator
- Rina Consulting - Centro Sviluppo Materiali SpA, Italy
- Runs
- 1 June 2022 to 31 May 2026
- Status
- Running
- EU funding
- €5.8m
- Total cost
- €5.8m
- Partners
- 15 organisations in 8 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101058751
What the project is doing
In the project's own words, from its summary on CORDIS.
Since the end of 2019, the spread of COVID has deeply changed our lifestyle, resulting in historical events and decisions, such as the EU block of non-essential travel among countries (COMM (2020) 499), affecting the whole EU society economically and psychologically. However, as reported in the HERA target priorities, the persistence of the emergency status requires daily actions that tackle the spread of COVID.In this economical, societal and clinical context, the project MIRIA aims to develop wide-range-antimicrobial nanocoatings to be used in hospitals and other environments where cross-contamination and contagion risk are significant issues.
In the wake of the covid outbreak, there has been large concern about infection spread of pathogens (i.e., bacteria, fungi, virus, and specifically SARS-CoV-2) via high traffic surfaces (i.e., medical equipment). State of the art and commercial products coating solutions that both target a range of mixed pathogens and different surfaces (e.g., glass, metal, textile) are unfortunately scant. MIRIA solutions aim to fill this void, impacting on EU health, both directly (by creating public safe environments) and indirectly (by reducing COVID spreading and decreasing ill-related work absences and psychological pathologies).
A reduction of the work absence of at least 5% with respect to the 2020 value (15M in EU) is expected. MIRIA main challenging ambition is to develop nanocoatings with a 99.99% effectiveness against a wide range of pathogens, especially SARS-CoV-2. This will be based on a four pieces puzzle: the knowledge in anti-microbial materials, nanopowders, nanocoating and pilot plant conduction. These nanocoatings will be brought to pilot scale (TRL6) and, within 3 years after the end of the project, they are foreseen to enter the market (TRL9).
The exploitation of MIRIA outputs deeply involves SMEs and the dissemination plan will follow a spill-over strategy in order to involve public and private stakeholders.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Rina Consulting - Centro Sviluppo Materiali SpA | Roma | Italy | Coordinator |
| Univerzita Karlova | Praha 1 | Czechia | Participant |
| Sud-Metall Beschlage GmbH | Ainring | Germany | Participant |
| Idener Research & Development Aie | Sevilla | Spain | Participant |
| Millidyne Oy | Tampere | Finland | Participant |
| Teknologian Tutkimuskeskus VTT Oy | Espoo | Finland | Participant |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Commissariat a L Energie Atomique Et Aux Energies Alternatives | Paris | France | Participant |
| Consorzio Interuniversitario Nazionale per La Scienza E Tecnologia Dei Materiali | Firenze | Italy | Participant |
| Protec Surface Technologies SRL | Bedizzole | Italy | Participant |
| Takis SRL | Roma | Italy | Participant |
| Alvo Medical Spolka Z Ograniczona Odpowiedzialnoscia | Smigiel | Poland | Participant |
| Helioenergia Spolka Z Ograniczona Odpowiedzialnoscia | Czerwionka-Leszczyny | Poland | Participant |
| Siec Badawcza Lukasiewicz - Instytut Metali Niezelaznych | Gliwice | Poland | Participant |
| Cellcomb AB | Saffle | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI